Published

Psychedelics and Psychedelic-Assisted Psychotherapy.

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: The American journal of psychiatry
Date: 2020-05-01
Source: PubMed
DOI: 10.1176/appi.ajp.2019.19010035
PubMed: 32098487

Authors

Reiff CM Richman EE Nemeroff CB Carpenter LL Widge AS Rodriguez CI Kalin NH McDonald WM the Work Group on Biomarkers and Novel Treatments a Division of the American Psychiatric Association Council of Research

Watch author

Derived topics and classifications

psilocybin Depression Anxiety PTSD End-of-Life Distress Brain Imaging Aging Clinical Trial Review Article Observational Study Cancer Patients Treatment-Resistant Depression Clinical Trial

Citation graph

0 referenced DOIs found in stored source metadata. 10 indexed papers cite this DOI.

Open citation network

Indexed papers citing this DOI

Prevalence and Reasons for Microdosing Cannabis, Psilocybin, LSD, and MDMA Among U.S. Adults2026-10-01 Cardiovascular safety of psilocybin in psychiatric practice: a narrative review2026-08-01 Past-Year Psilocybin and Alcohol Co-Use: Associations With Mental Health Symptoms2026-07-01 Efficacy of Psilocybin-Assisted Therapy in Major Depressive Disorder: A Systematic Review and Meta-Analysis2026-06-15 Examining the effects of psilocybin-assisted psychotherapy on anhedonia in treatment-resistant depression2026-06-01 Prevalence and Correlates of Past-Year Psilocybin Use in the United States2026-04-22 The efficacy and safety of psilocybin-assisted therapy for major depressive disorder: a meta-analytic review of clinical outcomes2026-04-21 Consistency of protocol and safety data reporting in clinical trial registrations and corresponding publications of interventions involving MDMA and psilocybin2026-04-01 Psilocybin effects on brain functional connectivity: a systematic review of fMRI studies2026-03-19 Psychedelics and Psychedelic-Assisted Psychotherapy.2020-05-01

Related papers

Neuroplasticity Enhancement From Cognitive Training Reinforced by Psilocybin (NECTAR) in Aging and Alzheimer's DiseaseClinicalTrials.gov · 2026-08-07 Low-Dose Psilocybin Therapy for Palliative Care Patients With Chronic Cancer Pain Requiring OpioidsClinicalTrials.gov · 2026-08-12 The Utility of Psilocybin in Managing Anxiety and Depression in Cancer PatientsBiochemistry and Molecular Biology Education · 2018-08-01 Multivariate Neural and Physiological Correlates of Psychedelic Sub-states: a Within-subjects, Healthy Volunteer Study With Experience-samplingClinicalTrials.gov · 2026-06-05 Comparing Neural Correlates of Consciousness: From Psychedelics to Hypnosis and Meditation.Biological psychiatry. Cognitive neuroscience and neuroimaging · 2024-05-01 Serotonergic Psychedelics: A Comparative Review of Efficacy, Safety, Pharmacokinetics, and Binding Profile.Biological psychiatry. Cognitive neuroscience and neuroimaging · 2024-05-01 An Examination of Psilocybin Effects on Biomarkers of Longevity, Healthy Aging, and Purpose in LifeClinicalTrials.gov · 2026-08-17 The Effects of Psilocybin on Self-Focus and Self-Related Processing in Major Depressive DisorderClinicalTrials.gov · 2026-08-13